ArticleEuropean journal of clinical pharmacology2026

Comment on "Dose-dependent efficacy and safety of Filgotinib in moderate to severe Crohn's disease: a grade-assessed systematic review and meta-analysis of randomized controlled trials".

Tanjima Tarique Laskar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.